STOCK TITAN

[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Martin Roper, CEO and Director of Vita Coco Company, Inc. (COCO), reported sales of common stock on 09/12/2025 executed under a Rule 10b5-1 trading plan. The filing shows four sell transactions of 5,000 shares each at weighted-average prices around $40.01, reducing the reporting person's direct beneficial ownership to 352,062 shares. Separate lines show indirect holdings of 286,131 shares held by each of three family trusts and 61,200 shares held by a spouse. The form also discloses multiple fully vested and outstanding non-qualified stock options with various exercise prices and vesting schedules, including options exercisable for 579,670 shares and others vesting through 2035.

Martin Roper, amministratore delegato e direttore di Vita Coco Company, Inc. (COCO), ha riportato vendite di azioni ordinarie in data 12/09/2025 effettuate secondo un piano di negoziazione Rule 10b5-1. La pratica riporta quattro operazioni di vendita da 5.000 azioni ciascuna ad un prezzo medio ponderato di circa $40,01, riducendo la detenzione diretta del soggetto dichiarante a 352.062 azioni. In righe separate compaiono posizioni indirette di 286.131 azioni detenute da tre trust familiari, e 61.200 azioni detenute dal coniuge. Il modulo segnala inoltre multiple opzioni su azioni non qualificate, pienamente acquisite e con varied exercise prices e piani di vesting, inclusa opzione esercitabile per 579.670 azioni e altre che maturano entro il 2035.

Martin Roper, CEO y Director de Vita Coco Company, Inc. (COCO), reportó ventas de acciones comunes el 12/09/2025 realizadas bajo un plan de negociación Rule 10b5-1. La presentación muestra cuatro operaciones de venta de 5,000 acciones cada una a precios ponderados cercanos a $40,01, reduciendo la titularidad directa beneficiosa reportada a 352,062 acciones. Líneas separadas muestran participaciones indirectas de 286,131 acciones en manos de tres fideicomisos familiares y 61,200 acciones en poder del cónyuge. El formulario también divulga múltiples opciones sobre acciones no calificadas, totalmente adquiridas y vigentes con varios precios de ejercicio y calendarios de vesting, incluidas opciones ejercitables para 579,670 acciones y otras que vencen hasta 2035.

Martin Roper, Vita Coco Company, Inc. (COCO)의 CEO 겸 이사로서 2025년 9월 12일 Rule 10b5-1 거래 계획에 따라 자사보통주 매도 거래를 보고했습니다. 공시에는 평균가가 약 $40.01인 각 5,000주씩의 네 건의 매도 거래가 표시되어 보고자(공개자)의 직접적 유익 소유를 352,062주로 감소시켰습니다. 별도의 줄에는 세 가족 신탁이 보유한 간접 보유 286,131주와 배우자 보유분 61,200주가 표시됩니다. 또한 양식은 다양한 행사 가격과 vesting 일정이 있는 다수의 완전 귀속 비적격 주식 옵션을 공개하며, 행사 가능 옵션은 579,670주에 이르고 다른 옵션은 2035년까지 vesting됩니다.

Martin Roper, PDG et administrateur de Vita Coco Company, Inc. (COCO), a déclaré des ventes d’actions ordinaires le 12/09/2025 effectuées dans le cadre d’un plan de négociation Rule 10b5-1. Le dépôt montre quatre ventes de 5 000 actions chacune à des prix moyens pondérés autour de 40,01 $, réduisant la détention bénéficiaire directe du déclarant à 352 062 actions. Des lignes séparées indiquent des participations indirectes de 286 131 actions détenues par chacun de trois fiducies familiales et 61 200 actions détenues par le conjoint. Le formulaire divulge également de multiple options sur actions non qualifiées entièrement acquises et en vigueur, avec divers prix d’exercice et calendriers de vesting, y compris des options exercables pour 579 670 actions et d’autres qui se libèrent jusqu’en 2035.

Martin Roper, CEO und Direktor der Vita Coco Company, Inc. (COCO), meldete am 12.09.2025 Verkäufe von Stammaktien, die im Rahmen eines Rule 10b5-1-Handelplans durchgeführt wurden. Die Einreichung zeigt vier Verkaufstransaktionen von jeweils 5.000 Aktien zu gewogenen Preisen um rund 40,01 $, wodurch die direkte beneficial ownership des meldenden Personen auf 352.062 Aktien sinkt. In separaten Zeilen werden indirekte Anteile von 286.131 Aktien angezeigt, die jeweils von drei Familientrusts gehalten werden, sowie 61.200 Aktien, die dem Ehepartner gehören. Das Formular offenbart außerdem mehrere vollständig vestete und outstandende nicht qualifizierte Aktienoptionen mit unterschiedlichen Ausübungspreisen und Vesting-Plänen, darunter Optionen, die für 579.670 Aktien ausübbar sind, und weitere, die bis 2035 vesten.

مارتن روبر، الرئيس التنفيذي والمدير في شركة Vita Coco Company, Inc. (COCO)، قد أبلغ عن مبيعات لأسهم عادية في 12/09/2025 والتي تمت بموجب خطة تداول Rule 10b5-1. يظهر الملف أربع صفقات بيع كل منها 5,000 سهم بسعر تقريبي متوسط قدره 40.01 دولار، مما قلل الملكية المفيدة المباشرة للمبلغ المصرح عنه إلى 352,062 سهماً. خطوط منفصلة تُظهر ملكيات غير مباشرة قدرها 286,131 سهماً مملوكة من ثلاث ائتمانات عائلية و 61,200 سهم مملوكة من قبل الزوج/الزوجة. كما يكشف النموذج عن خيارات أسهم غير مقيدة مملوكة بالكامل وموجودة مع أسعار ممارسة وجدولة اندماج متعددة، بما في ذلك خيارات قابلة لممارسة لـ 579,670 سهماً وأخرى تستحق حتى 2035.

Martin Roper,Vita Coco Company, Inc.(COCO)的首席执行官兼董事,已据 Rule 10b5-1 交易计划于 2025 年 9 月 12 日披露了普通股的出售。 备案显示四笔各 5,000 股的出售交易,加权平均价格约为 $40.01,报告人直接持有的受益所有权降至 352,062 股。单独的行显示由三份家庭信托各持有的 间接持股 286,131 股,以及由配偶持有的 61,200 股。 表格还披露多项完全归属并且尚未行使的非合格股票期权,具有不同的行使价格和归属安排,包括可行使的 579,670 股期权,以及其他至 2035 年才归属的期权。

Positive
  • Sales were executed under a Rule 10b5-1 trading plan, indicating pre-arranged dispositions rather than opportunistic trades
  • Reporting person retains substantial equity and option holdings, including a fully vested option covering 579,670 shares
Negative
  • Insider sold 20,000 shares on 09/12/2025, reducing direct ownership to 352,062 shares

Insights

TL;DR: Insider sales under a 10b5-1 plan reduced direct holdings but left substantial equity and many vested options.

The Form 4 documents systematic sales totaling 20,000 common shares on 09/12/2025, executed pursuant to a Rule 10b5-1 plan, at weighted-average prices near $40. These transactions lowered the reporting person's direct stake to 352,062 shares while sizable indirect holdings remain via family trusts and spouse. The filing also lists large option positions, including a fully vested option covering 579,670 shares exercisable at $10.178 and multiple other option tranches with exercise prices through $32.78 and vesting into 2035. For investors, this shows liquidity-taking by an insider without elimination of meaningful ownership and with substantial option-based incentives remaining.

TL;DR: Sales appear routine and pre-planned; continued indirect family holdings and long-dated options indicate ongoing alignment.

The filing explicitly states the sales were made under a Rule 10b5-1 trading plan, which typically signals pre-arranged, non-tactical dispositions. Direct ownership was reduced to 352,062 shares while identical indirect balances (286,131) are reported for three family trusts, and 61,200 shares are held by a spouse, reflecting concentrated family ownership. Multiple non-qualified stock options—including a large fully vested tranche—remain outstanding, preserving incentive alignment. No amendments or unusual disclosures are present in the form.

Martin Roper, amministratore delegato e direttore di Vita Coco Company, Inc. (COCO), ha riportato vendite di azioni ordinarie in data 12/09/2025 effettuate secondo un piano di negoziazione Rule 10b5-1. La pratica riporta quattro operazioni di vendita da 5.000 azioni ciascuna ad un prezzo medio ponderato di circa $40,01, riducendo la detenzione diretta del soggetto dichiarante a 352.062 azioni. In righe separate compaiono posizioni indirette di 286.131 azioni detenute da tre trust familiari, e 61.200 azioni detenute dal coniuge. Il modulo segnala inoltre multiple opzioni su azioni non qualificate, pienamente acquisite e con varied exercise prices e piani di vesting, inclusa opzione esercitabile per 579.670 azioni e altre che maturano entro il 2035.

Martin Roper, CEO y Director de Vita Coco Company, Inc. (COCO), reportó ventas de acciones comunes el 12/09/2025 realizadas bajo un plan de negociación Rule 10b5-1. La presentación muestra cuatro operaciones de venta de 5,000 acciones cada una a precios ponderados cercanos a $40,01, reduciendo la titularidad directa beneficiosa reportada a 352,062 acciones. Líneas separadas muestran participaciones indirectas de 286,131 acciones en manos de tres fideicomisos familiares y 61,200 acciones en poder del cónyuge. El formulario también divulga múltiples opciones sobre acciones no calificadas, totalmente adquiridas y vigentes con varios precios de ejercicio y calendarios de vesting, incluidas opciones ejercitables para 579,670 acciones y otras que vencen hasta 2035.

Martin Roper, Vita Coco Company, Inc. (COCO)의 CEO 겸 이사로서 2025년 9월 12일 Rule 10b5-1 거래 계획에 따라 자사보통주 매도 거래를 보고했습니다. 공시에는 평균가가 약 $40.01인 각 5,000주씩의 네 건의 매도 거래가 표시되어 보고자(공개자)의 직접적 유익 소유를 352,062주로 감소시켰습니다. 별도의 줄에는 세 가족 신탁이 보유한 간접 보유 286,131주와 배우자 보유분 61,200주가 표시됩니다. 또한 양식은 다양한 행사 가격과 vesting 일정이 있는 다수의 완전 귀속 비적격 주식 옵션을 공개하며, 행사 가능 옵션은 579,670주에 이르고 다른 옵션은 2035년까지 vesting됩니다.

Martin Roper, PDG et administrateur de Vita Coco Company, Inc. (COCO), a déclaré des ventes d’actions ordinaires le 12/09/2025 effectuées dans le cadre d’un plan de négociation Rule 10b5-1. Le dépôt montre quatre ventes de 5 000 actions chacune à des prix moyens pondérés autour de 40,01 $, réduisant la détention bénéficiaire directe du déclarant à 352 062 actions. Des lignes séparées indiquent des participations indirectes de 286 131 actions détenues par chacun de trois fiducies familiales et 61 200 actions détenues par le conjoint. Le formulaire divulge également de multiple options sur actions non qualifiées entièrement acquises et en vigueur, avec divers prix d’exercice et calendriers de vesting, y compris des options exercables pour 579 670 actions et d’autres qui se libèrent jusqu’en 2035.

Martin Roper, CEO und Direktor der Vita Coco Company, Inc. (COCO), meldete am 12.09.2025 Verkäufe von Stammaktien, die im Rahmen eines Rule 10b5-1-Handelplans durchgeführt wurden. Die Einreichung zeigt vier Verkaufstransaktionen von jeweils 5.000 Aktien zu gewogenen Preisen um rund 40,01 $, wodurch die direkte beneficial ownership des meldenden Personen auf 352.062 Aktien sinkt. In separaten Zeilen werden indirekte Anteile von 286.131 Aktien angezeigt, die jeweils von drei Familientrusts gehalten werden, sowie 61.200 Aktien, die dem Ehepartner gehören. Das Formular offenbart außerdem mehrere vollständig vestete und outstandende nicht qualifizierte Aktienoptionen mit unterschiedlichen Ausübungspreisen und Vesting-Plänen, darunter Optionen, die für 579.670 Aktien ausübbar sind, und weitere, die bis 2035 vesten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Roper Martin

(Last) (First) (Middle)
250 PARK AVE SOUTH
SEVENTH FLOOR

(Street)
NEW YORK NY 10003

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/12/2025 S(1) 5,000 D $40.015(2) 352,062 D
Common Stock 09/12/2025 S(1) 5,000 D $40.008(3) 286,131 I by Chris Roper FT(4)
Common Stock 09/12/2025 S(1) 5,000 D $40.005(5) 286,131 I by Peter Roper FT(6)
Common Stock 09/12/2025 S(1) 5,000 D $40.019(7) 286,131 I by Thomas Roper FT(8)
Common Stock 61,200 I by Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $10.178 (9) 09/19/2029 Common Stock 579,670 579,670 D
Non-Qualified Stock Option (right to buy) $10.178 (10) 01/11/2031 Common Stock 40,950 40,950 D
Non-Qualified Stock Option (right to buy) $15 (11) 10/21/2031 Common Stock 298,507 298,507 D
Non-Qualified Stock Option (right to buy) $16.91 (12) 03/10/2033 Common Stock 46,875 46,875 D
Non-Qualified Stock Option (right to buy) $26.18 (13) 03/04/2034 Common Stock 62,743 62,743 D
Non-Qualified Stock Option (right to buy) $32.78 (14) 03/03/2035 Common Stock 70,715 70,715 D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4. These shares are held by the Christopher G. Roper Exempt Family Trust.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
6. These shares are held by the Peter S. Roper Exempt Family Trust.
7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
8. These shares are held by the Thomas L. Roper Exempt Family Trust.
9. The stock option is fully vested and currently exercisable.
10. The stock option is fully vested and currently exercisable.
11. The stock option vests in four equal annual installments beginning on November 27, 2022.
12. The stock option vests in four equal annual installments beginning on March 10, 2024.
13. The stock option vests in four equal annual installments beginning on March 4, 2025.
14. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
By: Alison Klein, Attorney-in-Fact For: Martin Roper 09/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions are reported for Martin Roper on Form 4 for COCO?

The Form 4 reports four sales of 5,000 common shares each on 09/12/2025 (totaling 20,000 shares) executed under a Rule 10b5-1 plan.

How many shares does Martin Roper directly own after the reported sales?

The filing shows 352,062 shares beneficially owned directly following the reported transactions.

Are there indirect holdings disclosed for the reporting person in the COCO Form 4?

Yes. The Form 4 discloses 286,131 shares held by each of three family trusts and 61,200 shares held by a spouse as indirect beneficial ownership.

Does the Form 4 disclose any stock options for Martin Roper?

Yes. Multiple non-qualified stock options are reported, including a fully vested option for 579,670 shares exercisable at $10.178, and other option tranches with exercise prices through $32.78 vesting up to 2035.

Were the reported sales single transactions or multiple trades?

The filing states the reported prices are weighted averages and that the shares were sold in multiple transactions at prices in specified ranges around $40.00.
Vita Coco Company, Inc.

NASDAQ:COCO

COCO Rankings

COCO Latest News

COCO Latest SEC Filings

COCO Stock Data

2.29B
50.73M
10.67%
85.62%
8.23%
Beverages - Non-Alcoholic
Beverages
Link
United States
NEW YORK